by Team Archbow | Apr 9 | Distribution, Market Access, Patient Access, Specialty Pharmacy, Strategy
INSIGHTS Home 9 Tag: Biotech • Revolutionizing Patient Support: Creating a Seamless, Patient-Centered Experience For manufacturers looking to improve outcomes, ensure operational excellence, and deliver lasting value to customers, building...
by Rob Besse | Feb 4 | Distribution, Strategy
INSIGHTS Home 9 Tag: Manufacturer • Fair Market Value vs. Current Market Leverage How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for...
by Team Archbow | Jan 14 | Distribution, Industry News, Market Access, Strategy
INSIGHTS Home 9 Tag: Biotech • ECRM 2025: Key Trends & Opportunities Archbow Consulting uncovered valuable pharma insights at ECRM including optimizing supply chain solutions and refining market access strategies. ECRM 2025: Key...
by Team Archbow | Dec 17 | Distribution, HUBs, Market Access, Patient Access, Specialty Pharmacy, Technology
INSIGHTS Home 9 Tag: Biotech • Navigating the Evolving Pharma Landscape: A Year in Review Archbow Consulting’s insights served as a valuable resource for navigating a year of evolving trends. Navigating the Evolving Pharma Landscape...
by Shannon Hybner | Oct 23 | All
INSIGHTS Home 9 Tag: Wholesale r • FDA Extends Compliance Deadline for Updated DSCSA Requirements The U.S. FDA recently announced a revised timeline for compliance with specific updated Drug Supply Chain Security Act (DSCSA) requirements....
